Premier Expects FY25 Net Revenue Of $930M-$1.02B Vs $977.19M Est, Adj EPS Of $1.16-$1.28 Vs $1.21 Est
Premier Expects FY25 Net Revenue Of $930M-$1.02B Vs $977.19M Est, Adj EPS Of $1.16-$1.28 Vs $1.21 Est
首席執行官預計FY25年淨營業收入爲93000萬美元。10.2億美元,相比於預估的97719萬美元,調整後的每股收益爲1.16美元至1.28美元,預估值爲1.21美元
Fiscal 2025 Guidance
2025財年指導
Certain statements in this release, including without limitation, those in this section, are forward-looking statements. For additional information regarding the use and limitations of such statements, refer to "Cautionary Note Regarding Forward-Looking Statements" below.
本發佈中的某些聲明,包括但不限於本節中的內容,均屬前瞻性聲明。有關此類聲明的使用和限制的詳細信息,請參閱下文的"關於前瞻性聲明的警示"。
Based on results for the first quarter of fiscal 2025 and its current outlook for the remainder of the fiscal year, the company is reaffirming the following:
根據2025財年第一季度的業績以及公司對整個財年的當前展望,公司重申以下內容:
Guidance Metric | Fiscal 2025 Guidance Range [1] [2] (as of November 5, 2024) |
Segment Net Revenue: | |
Supply Chain Services | $560 million to $610 million |
Performance Services Excluding Contigo Health | $370 million to $410 million |
Total Net Revenue Excluding Contigo Health | $930 million to $1.02 billion |
Adjusted EBITDA | $235 million to $255 million |
Adjusted EPS | $1.16 to $1.28 |
Fiscal 2025 guidance is based on the realization of the following key assumptions:
|
指導指標 | 2025財年指導區間[1] [2](截至2024年11月5日) |
業務部門淨營收: | |
供應鏈服務 | 56000萬到61000萬美元 |
不包括康蒂戈健康的業績服務 | 37000萬到41000萬美元 |
不包括康蒂戈健康的總淨營業收入 | 93000萬到10.2億美元 |
調整後的EBITDA | 23500萬到25500萬美元 |
調整後的每股收益 | 每股收益爲$1.16至$1.28 |
2025財年的指導原則基於以下關鍵假設的實現:
|
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。